4.3. Strengths
postoperative pain, pain
POSTOPERATIVE FEVER, COMPLICATIONS
The strength of this study was that it is a multicenter, randomized, controlled, and prospective study. Not only were dynamic pain intensity scores considered as the important concern, but also the AUC of VAS for each time period and patient satisfaction were included in the outcome index, which was essential for the recovery of overall function. More importantly, we indicated the lack data of treatment for IVIB 400 mg on postoperative pain, compared to 800 mg and added the existing data to explain that 30 min infusion time and q6h of IVIB 400 mg and 800 mg potentially reduced complications associated with postoperative fever, such as longer hospitalization, avoidable healthcare costs, and increased morbidity for patients. In a word, it provided physicians with strategies for ibuprofen-assisted postoperative analgesia by assessing the safety and efficacy.